Monopar Therapeutics Inc.

NASDAQ: MNPR · Real-Time Price · USD
35.87
0.01 (0.03%)
At close: Aug 15, 2025, 3:59 PM
35.71
-0.45%
After-hours: Aug 15, 2025, 04:10 PM EDT

Monopar Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-5.08B -2.62M -10.93M -1.3K -1.72M -1.64M -1.81M -1.95M -2.2M -2.43M -2.9M -2.4M -2.76M -2.46M -2.68M -2.46M -2.08M -1.88M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
1.28B 1.36M 278.61K 861.84M 334.39K 328.66K 474.21K 474.14K 473.3K 476.21K 393.42K 390.74K 357.29K 499.81K 350.16K 392.06K 357.59K 368.23K
Other Working Capital
3.62M -3.62M 2.96M 2.96K 49.87K -31.62K 6.81K 36.67K -3.05K -60.84K 5.25K 4.49K 2.58K 21.73K -42.09K -11.24K 19K -51.88K
Other Non-Cash Items
-2.94B n/a 4.55M -863.55M n/a n/a n/a n/a 845.02K 728.13K -802.45K -277.53 -734.99K 1.03M 9.55K 255.77K 60.14K 738.63K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
4.39M -4.39M 4.1M 638.74K -295.88K -342.86K -206.19K -460.22K -374.77K -312.77K 1.2M -139.57K 1.09M -510.59K 298.52K 125.06K 316.46K -422.27K
Operating Cash Flow
-6.74B -5.66M -2M -1.07M -1.68M -1.66M -1.55M -1.94M -2.1M -2.27M -1.3M -2.15M -1.31M -2.47M -2.03M -1.94M -1.41M -1.94M
Capital Expenditures
4.00 -4 n/a n/a n/a 3.00 n/a 3.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-3.14B -1.93M -14.34M n/a -2.42K -983.31K 9.24K -2.97M -1.96M -2.96M -4.92M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
4B 1.6M n/a 985.73K n/a n/a 2.96M 2.96M 4.92M 1.98M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a 2.95K -983.44 -4.92K n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
861.79M -325.83K -14.34M 985.73K -2.42K -983.31K 2.97M -13.05K 2.95M -983.44K -4.92M n/a n/a n/a n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a -16.53 n/a n/a n/a n/a n/a n/a n/a -10.67K -29.66 -16.67 -7.77 -9.98 -24 n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-432.41M -131.13K -66.95K -16.52K -10K -10.74K -5.32K -8.21K -16.61K -16.83K 29.4K -13.07K -65.46K -16.67K -7.77K -9.98K -24K -4.02K
Financial Cash Flow
-432.41M -115.68K 56.14M -16.53K -9.92K 3.18M 334.55K 246.7K 641.18K 804.8K 138.74K -23.74K -65.46K -16.67K -7.77K -9.98K -24K 10.92M
Net Cash Flow
39.46B -6.1M 39.8M -99.85K -1.69M 541.5K 1.75M -1.7M 1.49M -2.46M -6.13M -2.15M -1.36M -2.48M -2.04M -1.95M -1.43M 8.99M
Free Cash Flow
-6.74B -5.66M -2M -1.07M -1.68M -1.66M -1.55M -1.94M -2.1M -2.27M -1.3M -2.15M -1.31M -2.47M -2.03M -1.94M -1.41M -1.94M